Natamycin | CAS 7681-93-8 - Request Quote
Natamycin
| SZ CAT No: | SZ-N095001 |
| CAS No | 7681-93-8 |
| Mol.F. | C33H47NO13 |
| Mol.Wt. | 665.7 |
| Inv. Status | Synthesis on demand |
| Shipping Condition | Room Temperature |
Chemical Name :
Synonym :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Natamycin is chemically (1R,3S,5R,7R,8E,12R,14E,16E,18Z,20E,22R,24S,25R,26S)-22-(((2R,3S,4S,5S,6R)-4-Amino-3,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-trioxatricyclo[22.3.1.05,7]octacosa-8,14,16,18,20-pentaene-25-carboxylic acid. It is also known as Pimaricin,Tennecetin. Natamycin is supplied with detailed characterization data compliant with regulatory guideline. Natamycin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Natamycin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 7681-93-8
Purchase 7681-93-8
Order 7681-93-8
Enquire 7681-93-8
price of 7681-93-8
7681-93-8 Supplier
7681-93-8 Manufacturer
7681-93-8 Exporter
buy high quality Natamycin
Purchase Natamycin
Natamycin suppliers
Natamycin manufacturers
Natamycin price
Order Natamycin
Enquire Natamycin
Natamycin cost
Natamycin Supplier
Natamycin Distributor
Natamycin for Method Validation
Natamycin Reference Standard
Natamycin for ANDA Filing
Natamycin for Forced Degradation Studies
Natamycin Identification Standards
Natamycin for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.